GSK 329

Pricing Availability   Qty
Description: Potent and selective TNNI3K inhibitor, orally bioavailable
Chemical Name: N-[3,5-Dichloro-4-[[6-(methylamino)-4-pyrimidinyl]oxy]phenyl]-N'-[3-(trifluoromethyl)phenyl]urea
Purity: ≥98% (HPLC)
Datasheet
Citations
Reviews
Literature (1)

Biological Activity for GSK 329

GSK 329 is a potent and selective TNNI3K (cardiac troponin I-interacting kinase) inhibitor (IC50 = 10 nM). It exhibits selectivity for TNNI3K over human VEGFR2 (40-fold), p38α (80-fold), B-Raf (>200-fold) and displays >100-fold selectivity over 80% of 185 kinases tested. In vivo, GSK 329 reduces infarct size, ROS levels, and p38 activation in a mouse model of ischemia/reperfusion cardiac injury. This compound is orally bioavailable.

Technical Data for GSK 329

M. Wt 472.25
Formula C19H14Cl2F3N5O2
Storage Store at -20°C
Purity ≥98% (HPLC)
CAS Number 1268490-12-5
PubChem ID 50997674
InChI Key QOQADIYOLOHRAW-UHFFFAOYSA-N
Smiles CNC1=CC(OC2=C(C=C(C=C2Cl)NC(NC3=CC(C(F)(F)F)=CC=C3)=O)Cl)=NC=N1

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

Solubility Data for GSK 329

Solvent Max Conc. mg/mL Max Conc. mM
Solubility
DMSO 47.23 100
ethanol 9.45 20

Preparing Stock Solutions for GSK 329

The following data is based on the product molecular weight 472.25. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Select a batch to recalculate based on the batch molecular weight:
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 2.12 mL 10.59 mL 21.18 mL
5 mM 0.42 mL 2.12 mL 4.24 mL
10 mM 0.21 mL 1.06 mL 2.12 mL
50 mM 0.04 mL 0.21 mL 0.42 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

References for GSK 329

References are publications that support the biological activity of the product.

Patterson et al (2021) Identification of diarylurea inhibitors of the cardiac-specific kinase TNNI3K by designing selectivity against VEGFR2, p38a, and B-Raf. J.Med.Chem. 64 15651 PMID: 34699203

Vagnozzi et al (2013) Inhibition of the cardiomyocyte-specific kinase TNNI3K limits oxidative stress, injury, and adverse remodeling in the ischemic heart. Sci.Transl.Med. 5 207ra141 PMID: 24132636


If you know of a relevant reference for GSK 329, please let us know.

View Related Products by Target

View Related Products by Product Action

View all Other MAPK Inhibitors

Keywords: GSK 329, GSK 329 supplier, GSK329, potent, selective, TNNI3K, inhibitors, inhibiTS, orally, bioavailable, kinases, MAPK, ischemia/reperfusion, cardiac, injury, in, vivo, Other, 7637, Tocris Bioscience

Citations for GSK 329

Citations are publications that use Tocris products.

Currently there are no citations for GSK 329. Do you know of a great paper that uses GSK 329 from Tocris? Please let us know.

Reviews for GSK 329

There are currently no reviews for this product. Be the first to review GSK 329 and earn rewards!

Have you used GSK 329?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Literature in this Area

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*Please note that Tocris will only send literature to established scientific business / institute addresses.


MAPK Signaling Scientific Review

MAPK Signaling Scientific Review

MAP kinase signaling is integral to the regulation of numerous cellular processes such as proliferation and differentiation, and as a result is an important focus of cancer and immunology research. Updated for 2016, this review discusses the regulation of the MAPK pathway and properties of MAPK cascades. Compounds available from Tocris are listed.